Key Study to be Presented at ESMO Virtual Congress 2020 Shows Nearly Half of Patients Receiving Immunotherapy are Unaware of Possible Financial Toxicity (FT)
Research Demonstrates Importance of Engaging Patients Throughout the Cancer Journey, Suggests Physicians Discuss FT from Moment of Diagnosis
San Francisco, CA (UroToday.com) — Belong.Life (Belong), a developer of social and professional networks for managing and navigating treatments, and the creator of the world’s largest social network for cancer patients has published a study showing that almost half of cancer patients receiving immunotherapy and suffering from Financial Toxicity (FT) were not aware of the possible development of FT prior to treatment. The research, which demonstrates the benefit of discussions about FT early on in the treatment journey, will be presented as a poster at the ESMO Virtual Congress 2020.